A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine

PHASE3CompletedINTERVENTIONAL
Enrollment

1,201

Participants

Timeline

Start Date

June 24, 2019

Primary Completion Date

July 31, 2020

Study Completion Date

August 13, 2020

Conditions
MigraineMigraine With AuraMigraine Without Aura
Interventions
DRUG

Dihydroergotamine

Dihydroergotamine is a semi-synthetic derivative of ergotamine tartrate.

DRUG

Placebos

Placebo for STS101

Trial Locations (117)

10036

Manhattan Behavioral Medicine, New York

10461

Montefiori Medical Center, The Bronx

11235

SPRI Clinical Trials, Brooklyn

14221

Upstate Clinical Research Associates, Williamsville

14609

Rochester Clinical Research, Rochester

19107

Thomas Jefferson University/Jefferson Headache Center, Philadelphia

22911

Charlottesville Medical Research, Charlottesville

27405

Headache Wellness Center - Greensboro, Greensboro

27408

PharmQuest, Greensboro

27612

M3-Wake Research, Raleigh

28401

PMG Research of Wilmington, Wilmington

30033

Neuro Studios, Decatur

32055

Multispecialty Research Associates, Lake City

32174

Neurology Associates of Ormond Beach, Ormond Beach

32256

CNS Healthcare, Jacksonville

32720

Accel Clinical - DeLand, DeLand

32751

ClinCloud, Maitland

32763

Accel - Orange City, Orange City

32789

Conquest Research, Winter Park

32801

CNS Health Care - Orlando, Orlando

33009

MD Clinical, Hallandale

33012

AGA Clinical Trials, Hialeah

33016

Galiz Research- Hialeah, Hialeah

33024

Research Centers of America, Hollywood

33122

Premier Clinical Reserch Institute, INC, Miami

33143

QPS MRA, Miami

33155

Applemed Research Group, Miami

Biotech Pharmaceuticals Group, Miami

33161

Behavioral Clinical Research, North Miami

33351

Infinity Clinical Research, LLC, Sunrise

Precision Clinical Research, Sunrise

33880

Clinical Research CF, Winter Haven

33912

Gulf Coast Clinical Research, Fort Myers

34761

Sensible Health, Ocoee

35216

Accel Clinical - Birmingham, Birmingham

35235

Alabama Clinical Therapeutics, Birmingham

37203

Clinical Research Associates, Nashville

Nashville Neuroscience Group, Nashville

37421

WR-ClinSearch, Chattanooga

38119

CNS Healthcare, Memphis

43213

Aventiv Research, Columbus

44122

Rapid Medical Research Inc., Cleveland

45212

CTI Clinical Research Center, Cincinnati

45459

Neurology Diagnosis, Dayton

48104

Michigan Headache and Neurological Institute, Ann Arbor

49519

Michigan Pain Consultants, Wyoming

55337

Minneapolis Clinic of Neurology, Burnsville

58104

Lillestol Research, Fargo

59808

Montana Medical Research, Missoula

60422

Healthcare Research Network II, LLC, Flossmoor

60515

PMG Research of DuPage Medical Group, Downers Grove

63042

Healthcare Research Network II, LLC, Hazelwood

63303

StudyMetrix Research, City of Saint Peters

65810

Clinvest Research, Springfield

66208

Phoenix Medical Reserch, Prairie Village

68114

Quality Clinical Research, Omaha

70072

Tandem Clinical Research, Marrero

70124

Delricht - NewOrleans, New Orleans

70816

Delricht - Baton Rouge, Baton Rouge

73112

Delynn Institute, Oklahoma City

74133

Delricht Research, Tulsa

75013

Wellness Clinical Research, Allen

75149

SMS Clinical Research, Mesquite

75165

ClinPoint Trials, Waxahachie

75231

Future Search Trials, Dallas

75240

HRMD Research, Dallas

77081

Texas Center for Drug Development, Houston

77375

DM Clinical Research, Tomball

78731

FutureSearch Trials of Neurology, Austin

83642

Advanced Clinical Research, Meridian

84058

Aspen Clinical Research, Orem

84107

Wasatch Clinical Research, Salt Lake City

84124

Highland Clinical Research, Salt Lake City

85012

Alea Research, Phoenix

85018

Elite Clinical Studies, Phoenix

85053

Arizona Research Center, Phoenix

85710

Tucson Neuroscience Research, Tucson

87109

Albuquerque Clinical Trials, Albuquerque

Albuquerque Neuroscience, Albuquerque

89102

Altea Research, Las Vegas

89118

Wake Research-Clinical Research Center of Nevada, Las Vegas

89121

Clinical Research of South Nevada, Las Vegas

90017

Downtown LA Research, Los Angeles

90024

Cal Neuro Research Group, Los Angeles

90404

Neurological Research Institute, Santa Monica

90720

WP-PRI, Los Alamitos

90806

Collaborative Neuroscience, Long Beach

91316

WR-PRI, Encino

91402

National Research Institute, Panorama City

91403

Schuster Medical Research Institute, Sherman Oaks

91767

Empire Clinical Reserch, Pomona

91942

eStudySite, La Mesa

91978

Encompass Clinical Research, Spring Valley

92011

The Research Center of Southern California, Carlsbad

92103

Artemis Institute of Clinical Research - San Diego, San Diego

Pacific Research Network, San Diego

Artemis Institute for Clinical Research- San Marcos, San Marcos

92108

WR-MCCR, San Diego

92503

Artemis Institute for Clinical Research- Riverside, Riverside

92647

Marvel Clinical Research, Huntington Beach

92660

WR-PRI, Newport Beach

93065

Southern California Research, Simi Valley

94102

Optimus Medical Group, San Francisco

94304

Stanford Neuroscience Health Center, Palo Alto

94607

Alliance Sites, Oakland

95608

Med Center Medical Clinic, Carmichael

06118

Hartford Headache Center, East Hartford

06517

CMR of Greater New Haven, Hamden

06905

New England Institute for Neurology and Headache, Stamford

06708

Chase Medical Research, Waterbury

02131

Boston Clinical Trials, Boston

02740

BTC of New Bedford, New Bedford

02472

Medvadis Research Group, Watertown

03756

Dartmouth-Hitchcock Clinical Trials Office, Lebanon

08009

Hassman Research Institute, Berlin

02916

CNS Research Inc - Rhode Island, Rumford

02886

Omega Medical Research, Warwick

All Listed Sponsors
lead

Satsuma Pharmaceuticals, Inc.

INDUSTRY

NCT03901482 - A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine | Biotech Hunter | Biotech Hunter